Loading...

293 posters, 56 videos, 24 topics, 13 sessions, 658 authors, 215 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

ISMICS 2025 Annual Meeting

28 - 31 May, 2025 | Istanbul, Turkey

ISMICS 2025 Annual Meeting banner

D84

Right Axillary Artery Cannulation: A Standardized Approach In Minimally Invasive Coronary Surgery

Part of Topic

Education, Imaging and Facilitating Technologies

Video

Right Axillary Artery Cannulation: A Standardized Approach in Minimally Invasive Coronary Surgery

 

Objective:

This video demonstrates the standardized technique of direct right axillary artery (RAA) cannulation for antegrade perfusion during minimally invasive coronary artery bypass grafting (CABG). It highlights the advantages of this approach in patients with significant atherosclerosis, where retrograde femoral artery cannulation is contraindicated.  

Methods:

Between November 2019 and December 2023, 413 patients underwent CABG via left anterior minithoracotomy with cardiopulmonary bypass using RAA cannulation. Outcomes assessed included intraoperative complications, postoperative neurological events, and long-term cannulation-related issues.  

Results: 

RAA cannulation was successful in 100% of cases, with minimal intraoperative complications and a postoperative stroke rate of 0.5%. Follow-up revealed no significant blood pressure discrepancies, permanent neurological deficits, or need for re-interventions.  

Conclusions: 

RAA cannulation provides a safe and effective strategy for antegrade perfusion in minimally invasive CABG, achieving excellent outcomes with minimal complications. This technique expands the applicability of minimally invasive approaches to a broader patient population.

ismics2025 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.